Search Results
Results found for "Dr. Juan Jose Fung"
- 📰 GPCR Weekly News, February 13 to 19, 2023
For Dr. GPCR News, please subscribe to our monthly newsletter. Research Fellow - School of Physics and Astronomy Postdoctoral Research Associate (Fixed Term) Explore Dr
- Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors
Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Thank you to all participants in Dr. Terry Kenakin's educational initiative this fall!
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
Chris Cargill appointed as President and Chief Executive Officer • Dr.
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE
- Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...
Ginsenoside Rg1, Polygalaxanthone III and Pachymic acid, could interact with multiple targets (5-HTR, DR
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
. 🎧 Listen to the full conversation with Dr. David Hodson
- GPCR Buzz of the Week | Sep 23 - 29, 2024
live and work in a developing country, please complete this form to enjoy complimentary access to Dr Photopharmacology GPCRs in Cardiology, Endocrinology, and Taste Rap1A Modulates Store-Operated Calcium Entry in the Lung
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..
In a LPS-induced lung inflammation model in mice, ACT-660602 led to significantly reduced recruitment of the CXCR3+ CD8+ T cell in the bronchoalveolar lavage compartment when administered orally at a dose
- 📰 GPCR Weekly News, January 30 to February 5, 2023
For Dr. GPCR News, please subscribe to your monthly newsletter. Research Fellow - School of Physics and Astronomy Postdoctoral Research Associate (Fixed Term) Explore Dr
- Why “Displacement” Misleads You: Allosteric Binding Demystified
As a member, you’ll get: Weekly expert-led lectures from Dr.
- 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
premium member , you can access over 500 minutes of exclusive, expert-led content from esteemed leaders, Drs
- 📰 GPCR Weekly News
team in Oxford, buying out a fledgling biotech for $255M+ Domain Therapeutics announces first patient dosed Explore Dr. GPCR Ecosystem
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
Subscribers gain access to: Weekly lessons by Dr.
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
Here ’s what members get: Weekly deep dives from Dr.
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Thank you to all participants in Dr. Terry Kenakin's educational initiative this fall!
- 📰 GPCR Weekly News - January 2 to 8, 2023
Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
postdoctoral training at Boston Children’s Hospital and Harvard Medical School, he joined the lab of Dr
- Adhesion GPCR Consortium Newsletter - May 2024
postdoctoral training, I joined one of the labs that participated in Latrophilins’ discovery, the lab of Dr Don’t be surprised if you find yourself singing Daddy Yankee’s “Gasolina” from the top of your lungs
- How Collaboration Drives GPCR Discoveries
. 🎧 Listen to the full conversation with Dr. David Hodson
- 📰 GPCR Weekly News, January 23 to 29, 2023
of Staff Postdoctoral Fellow, Biochemical And Cellular Pharmacology Project Leader, Biology Explore Dr
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Monthly AMAs where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.
- 📰 GPCR Weekly News - January 9 to 15, 2023
Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
, you’re also unlocking over 500 minutes of exclusive, expert-led content from thought leaders like Drs
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
Where’s your dose justification? How consistent is your manufacturing? 2️⃣ Dose selection logic: Is there a clear, mechanistic, and empirical rationale for how you plan to dose in trials? future label claims , not just scientific curiosity You design preclinical studies that support your dose
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
It's starting to look a lot like Christmas at Dr. GPCR!
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...
In addition, Structure Therapeutics has completed dosing in a single ascending dose (SAD) Phase 1 study


















